In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

The free consultation period for this content is over.

It is now only available year-round to EHRA Ivory (& above) Members, Fellows of the ESC and Young combined Members

The quality of smartphone based heart rhythm monitoring using PPG technology in a large-scale free-living setting

Session Moderated ePosters 13: mobile and remote technologies: opportunities and challenges

Speaker Tine Proesmans

Event : EHRA 2019

  • Topic : e-cardiology / digital health, public health, health economics, research methodology
  • Sub-topic : Remote Patient Monitoring and Telemedicine
  • Session type : Moderated Posters

Authors : T Proesmans (Diepenbeek,BE), F Verbrugge (Genk,BE), J Vijgen (Hasselt,BE), W Mullens (Genk,BE), M Rivero-Ayerza (Genk,BE), H Van Herendael (Genk,BE), P Vandervoort (Genk,BE), D Nuyens (Genk,BE)

Authors:
T Proesmans1 , F Verbrugge2 , J Vijgen3 , W Mullens2 , M Rivero-Ayerza2 , H Van Herendael2 , P Vandervoort2 , D Nuyens2 , 1Hasselt University, Mobile Health Unit - Diepenbeek - Belgium , 2Hospital Oost-Limburg (ZOL) - Genk - Belgium , 3Virga Jesse Hospital - Hasselt - Belgium ,

Citation:

Introduction
Pulse-deriving smartphone applications have the potential to aid in the detection of atrial fibrillation. However, questions concerning their diagnostic capabilities, applicability in the relevant populations, and robustness remain to be answered.

Objective
This observational study evaluated the applicability and robustness of a pulse-deriving smartphone application implemented in a broad population in a free-living setting.

Methods
A local newspaper published a free 7-day access code for a pulse-deriving smartphone application. Participants to this screening program received instructions on how to perform high quality measurements twice daily. To obtain a high quality signal, participants were instructed to adopt a sitting position with both arms resting on a firm surface, holding the smartphone in a vertical position with their dominant hand. Subsequently, the index finger of their non dominant hand should cover the flashlight and backside camera horizontally, without putting firm pressure

The smartphone application used in this study firstly checks acquired PPG signals for their quality. Compromised signals are not used for analysis to avoid inaccurate diagnostic results. Study participants with frequent poor quality PPG measurements received notifications through the application, guiding them on how to perform better measurements.

Results
From 12,328 readers who voluntarily signed up for screening (49±14 years; 58% men), 120,446 unique PPG traces were obtained. AF was detected in 136 individuals (1.1%).

PPG signal quality was sufficient for analysis in 110,713 measurements (92%). The frequency of measurements with insufficient quality for analysis decreased significantly during the screening period, from 17% on day 1 to 2% on day 7 (P-value<0.001), indicating a steep learning curve.  8,683 participants only performed high quality PPG measurements. They were significantly younger compared to participants with at least one insufficient quality measurement (49 versus 51 years old, P-value<0.001).

Conclusion
This study demonstrates the applicability and robustness of a pulse-deriving smartphone application in a broad population in an unsupervised setting, provided that efforts are focused on training and education. Awaiting further validation studies, these results indicate the potential of a pulse-deriving smartphone application to detect atrial fibrillation.

The free consultation period for this content is over.

It is now only available year-round to EHRA Ivory (& above) Members, Fellows of the ESC and Young combined Members

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are